Authors:
SCHMIT JC
MARTINEZPICADO J
RUIZ L
TURAL C
VANLAETHEM K
CABRERA C
IBANEZ A
PUIG T
WITVROUW M
DESMYTER J
DECLERCQ E
CLOTET B
VANDAMME AM
Citation: Jc. Schmit et al., EVOLUTION OF HIV DRUG-RESISTANCE IN ZIDOVUDINE ZALCITABINE-EXPERIENCED AND ZIDOVUDINE/DIDANOSINE-EXPERIENCED PATIENTS RECEIVING LAMIVUDINE-CONTAINING COMBINATION THERAPY/, Antiviral therapy, 3(2), 1998, pp. 81-88
Authors:
WITVROUW M
DAELEMANS D
PANNECOUQUE C
NEYTS J
ANDREI G
SNOECK R
VANDAMME AM
BALZARINI J
DESMYTER J
BABA M
DECLERCQ E
Citation: M. Witvrouw et al., BROAD-SPECTRUM ANTIVIRAL ACTIVITY AND MECHANISM OF ANTIVIRAL ACTION OF THE FLUOROQUINOLONE DERIVATIVE K-12, Antiviral chemistry & chemotherapy, 9(5), 1998, pp. 403-411
Authors:
DEBYSER Z
VANWIJNGAERDEN E
VANLAETHEM K
BEUSELINCK K
REYNDERS M
DECLERCQ E
DESMYTER J
VANDAMME AM
Citation: Z. Debyser et al., FAILURE TO QUANTIFY VIRAL LOAD WITH 2 OF THE 3 COMMERCIAL METHODS IN A PREGNANT WOMAN HARBORING AN HIV TYPE-1 SUBTYPE-G STRAIN, AIDS research and human retroviruses, 14(5), 1998, pp. 453-459
Authors:
SHENG L
SOUMILLION A
PEERLINCK K
VERSLYPE C
SCHELSTRAETE R
GYSELINCK F
EMONDS MP
HESS G
VERMYLEN J
DESMYTER J
YAP SH
Citation: L. Sheng et al., ANTI-HEPATITIS-G E2 ANTIBODY DETECTION AND ITS RELATION TO SERUM HGV-RNA IN PATIENTS WITH CLOTTING DISORDERS - HIGH PREVALENCE OF HGV INFECTION AND SPONTANEOUS REMISSION, Thrombosis and haemostasis, 79(4), 1998, pp. 752-755
Authors:
SCHMIT JC
VANLAETHEM K
RUIZ L
HERMANS P
SPRECHER S
SONNERBORG A
LEAL M
HARRER T
CLOTET B
ARENDT V
LISSEN E
WITVROUW M
DESMYTER J
DECLERCQ E
VANDAMME AM
Citation: Jc. Schmit et al., MULTIPLE DIDEOXYNUCLEOSIDE ANALOG-RESISTANT (MDDNR) HIV-1 STRAINS ISOLATED FROM PATIENTS FROM DIFFERENT EUROPEAN COUNTRIES, AIDS, 12(15), 1998, pp. 2007-2015
Authors:
HOPPENBROUWERS K
LAGOS R
SWENNEN B
ETHEVENAUX C
KNOPS J
LEVINE MM
DESMYTER J
Citation: K. Hoppenbrouwers et al., SAFETY AND IMMUNOGENICITY OF AN HAEMOPHILUS-INFLUENZAE TYPE B-TETANUSTOXOID CONJUGATE (PRP-T) AND DIPHTHERIA-TETANUS-PERTUSSIS (DTP) COMBINATION VACCINE ADMINISTERED IN A DUAL-CHAMBER SYRINGE TO INFANTS IN BELGIUM AND CHILE, Vaccine, 16(9-10), 1998, pp. 921-927
Authors:
SCHMIT JC
RUIZ L
STUYVER L
VANLAETHEM K
VANDERLINDEN I
PUIG T
ROSSAU R
DESMYTER J
DECLERCQ E
CLOTET B
VANDAMME AM
Citation: Jc. Schmit et al., COMPARISON OF THE LIPA HIV-1 RT TEST, SELECTIVE PCR AND DIRECT SOLID-PHASE SEQUENCING FOR THE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS, Journal of virological methods, 73(1), 1998, pp. 77-82
Authors:
VANLAETHEM K
BEUSELINCK K
VANDOOREN S
DECLERCQ E
DESMYTER J
VANDAMME AM
Citation: K. Vanlaethem et al., DIAGNOSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY A POLYMERASE-CHAIN-REACTION ASSAY EVALUATED IN PATIENTS HARBORING STRAINS OF DIVERSEGEOGRAPHICAL ORIGIN, Journal of virological methods, 70(2), 1998, pp. 153-166
Authors:
WITVROUW M
ARRANZ ME
PANNECOUQUE C
DECLERCQ R
JONCKHEERE H
SCHMIT JC
VANDAMME AM
DIAZ JA
INGATE ST
DESMYTER J
ESNOUF R
VANMEERVELT L
VEGA S
BALZARINI J
DECLERCQ E
Citation: M. Witvrouw et al., 1,1,3-TRIOXO-2H,4H-THIENO[3,4-E][1,2,4]THIADIAZINE (TTD) DERIVATIVES - A NEW CLASS OF NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE INHIBITORS WITH ANTI-HIV-1 ACTIVITY, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 618-623
Authors:
SALEMI M
VANDOOREN S
AUDENAERT E
DELAPORTE E
GOUBAU P
DESMYTER J
VANDAMME AM
Citation: M. Salemi et al., 2 NEW HUMAN T-LYMPHOTROPIC VIRUS TYPE-I PHYLOGENETIC SUBTYPES IN SEROINDETERMINATES, A MBUTI PYGMY AND A GABONESE, HAVE CLOSEST RELATIVES AMONG AFRICAN STLV-I STRAINS, Virology (New York, N.Y. Print), 246(2), 1998, pp. 277-287
Authors:
VANBRUSSEL M
SALEMI M
LIU HF
GABRIELS J
GOUBAU P
DESMYTER J
VANDAMME AM
Citation: M. Vanbrussel et al., THE SIMIAN T-LYMPHOTROPIC VIRUS STLV-PP1664 FROM PAN-PANISCUS IS DISTINCTLY RELATED TO HTLV-2 BUT DIFFERS IN GENOMIC ORGANIZATION, Virology, 243(2), 1998, pp. 366-379
Authors:
ESTE JA
CABRERA C
SCHOLS D
CHEREPANOV P
GUTIERREZ A
WITVROUW M
PANNECOUQUE C
DEBYSER Z
RANDO RF
CLOTET B
DESMYTER J
DECLERCQ E
Citation: Ja. Este et al., HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN GP120 AS THE PRIMARY TARGETFOR THE ANTIVIRAL ACTION OF AR177 (ZINTEVIR), Molecular pharmacology, 53(2), 1998, pp. 340-345
Authors:
VANDAMME AM
SALEMI M
VANBRUSSEL M
LIU HF
VANLAETHEM K
VANRANST M
MICHELS L
DESMYTER J
GOUBAU P
Citation: Am. Vandamme et al., AFRICAN ORIGIN OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-2 (HTLV-2) SUPPORTED BY A POTENTIAL NEW HTLV-2D SUBTYPE IN CONGOLESE BAMBUTI EFE PYGMIES, Journal of virology, 72(5), 1998, pp. 4327-4340
Authors:
SALEMI M
VANDAMME AM
GRADOZZI C
VANLAETHEM K
CATTANEO E
TAYLOR G
CASOLI C
GOUBAU P
DESMYTER J
BERTAZZONI U
Citation: M. Salemi et al., EVOLUTIONARY RATE AND GENETIC-HETEROGENEITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) USING ISOLATES FROM EUROPEAN INJECTING DRUG-USERS, Journal of molecular evolution, 46(5), 1998, pp. 602-611
Authors:
VANDOOREN S
GOTUZZO E
SALEMI M
WATTS D
AUDENAERT E
DUWE S
ELLERBROK H
GRASSMANN R
HAGELBERG E
DESMYTER J
VANDAMME AM
Citation: S. Vandooren et al., EVIDENCE FOR A POST-COLUMBIAN INTRODUCTION OF HUMAN T-CELL LYMPHOTROPIC VIRUS IN LATIN-AMERICA, Journal of General Virology, 79, 1998, pp. 2695-2708
Citation: Z. Debyser et al., COMPARATIVE-EVALUATION OF 3 ELISA TECHNIQUES AND AN INDIRECT IMMUNOFLUORESCENCE ASSAY FOR THE SEROLOGICAL DIAGNOSIS OF EPSTEIN-BARR-VIRUS INFECTION, Clinical and diagnostic virology, 8(1), 1997, pp. 71-81
Authors:
WITVROUW M
SCHMIT JC
VANREMOORTEL B
DAELEMANS D
ESTE JA
VANDAMME AM
DESMYTER J
DECLERCQ E
Citation: M. Witvrouw et al., CELL TYPE-DEPENDENT EFFECT OF SODIUM VALPROATE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN-VITRO, AIDS research and human retroviruses, 13(2), 1997, pp. 187-192
Authors:
LIU HF
GOUBAU P
VANBRUSSEL M
DESMYTER J
VANDAMME AM
Citation: Hf. Liu et al., PHYLOGENETIC ANALYSIS OF A SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I FROM A HAMADRYAS BABOON, AIDS research and human retroviruses, 13(17), 1997, pp. 1545-1548
Authors:
BEUTELS M
VANDAMME P
AELVOET W
DESMYTER J
DONDEYNE F
GOILAV C
MAK R
MUYLLE L
PIERARD D
STROOBANT A
VANLOOCK F
WAUMANS P
VRANCKX R
Citation: M. Beutels et al., PREVALENCE OF HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C IN THE FLEMISHPOPULATION, European journal of epidemiology, 13(3), 1997, pp. 275-280
Authors:
SHENG L
SOUMILLION A
PEERLINCK K
VERSLYPE C
VANPELT J
SCHELSTRAETE R
EMONDS MP
HESS G
DESMYTER J
VERMYLEN J
YAP SH
Citation: L. Sheng et al., DETECTION OF HGV-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) ANDIN SERUM OF ANTI-HGV-E2 POSITIVE HEMOPHILIACS, Hepatology, 26(4), 1997, pp. 784-784
Citation: Ggg. Donders et al., APPARENT FAILURE OF ONE INJECTION OF BENZATHINE PENICILLIN-G SYPHILISDURING PREGNANCY IN HUMAN IMMUNODEFICIENCY VIRUS-SERONEGATIVE AFRICANWOMEN, Sexually transmitted diseases, 24(2), 1997, pp. 94-101
Authors:
VANDAMME AM
VANLAETHEM K
LIU HF
VANBRUSSEL M
DELAPORTE E
COSTA CMDC
FLEISCHER C
TAYLOR G
BERTAZZONI U
DESMYTER J
GOUBAU P
Citation: Am. Vandamme et al., USE OF A GENERIC POLYMERASE CHAIN-REACTION ASSAY DETECTING HUMAN T-LYMPHOTROPIC VIRUS (HTLV) TYPE-I, TYPE-II AND DIVERGENT SIMIAN STRAINS IN THE EVALUATION OF INDIVIDUALS WITH INDETERMINATE HTLV SEROLOGY, Journal of medical virology, 52(1), 1997, pp. 1-7
Authors:
WITVROUW M
BALZARINI J
PANNECOUQUE C
JHAUMEERLAULLOO S
ESTE JA
SCHOLS D
CHEREPANOV P
SCHMIT JC
DEBYSER Z
VANDAMME AM
DESMYTER J
RAMADAS SR
DECLERCQ E
Citation: M. Witvrouw et al., SRR-SB3, A DISULFIDE-CONTAINING MACROLIDE THAT INHIBITS A LATE-STAGE OF THE REPLICATIVE CYCLE OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 262-268